160 related articles for article (PubMed ID: 20082228)
1. Pancreatic and extrapancreatic lesions in patients with intraductal papillary mucinous neoplasms of the pancreas: a single-centre experience.
Calculli L; Pezzilli R; Brindisi C; Morabito R; Casadei R; Zompatori M
Radiol Med; 2010 Apr; 115(3):442-52. PubMed ID: 20082228
[TBL] [Abstract][Full Text] [Related]
2. [Extrapancreatic tumors in intraductal papillary mucinous neoplasm of the pancreas].
Oh SJ; Lee SJ; Lee HY; Paik YH; Lee DK; Lee KS; Chung JB; Yu JS; Yoon DS
Korean J Gastroenterol; 2009 Sep; 54(3):162-6. PubMed ID: 19844152
[TBL] [Abstract][Full Text] [Related]
3. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
[TBL] [Abstract][Full Text] [Related]
4. Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas.
Pea A; Yu J; Rezaee N; Luchini C; He J; Dal Molin M; Griffin JF; Fedor H; Fesharakizadeh S; Salvia R; Weiss MJ; Bassi C; Cameron JL; Zheng L; Scarpa A; Hruban RH; Lennon AM; Goggins M; Wolfgang CL; Wood LD
Ann Surg; 2017 Jul; 266(1):133-141. PubMed ID: 27433916
[TBL] [Abstract][Full Text] [Related]
5. Multifocal branch-duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: magnetic resonance (MR) imaging pattern and evolution over time.
Castelli F; Bosetti D; Negrelli R; Di Paola V; Zantedeschi L; Ventriglia A; Manfredi R; Mucelli RP
Radiol Med; 2013 Sep; 118(6):917-29. PubMed ID: 23801393
[TBL] [Abstract][Full Text] [Related]
6. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.
Matthaei H; Norris AL; Tsiatis AC; Olino K; Hong SM; dal Molin M; Goggins MG; Canto M; Horton KM; Jackson KD; Capelli P; Zamboni G; Bortesi L; Furukawa T; Egawa S; Ishida M; Ottomo S; Unno M; Motoi F; Wolfgang CL; Edil BH; Cameron JL; Eshleman JR; Schulick RD; Maitra A; Hruban RH
Ann Surg; 2012 Feb; 255(2):326-33. PubMed ID: 22167000
[TBL] [Abstract][Full Text] [Related]
8. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
[TBL] [Abstract][Full Text] [Related]
9. Does secretin stimulation add to magnetic resonance cholangiopancreatography in characterising pancreatic cystic lesions as side-branch intraductal papillary mucinous neoplasm?
Purysko AS; Gandhi NS; Walsh RM; Obuchowski NA; Veniero JC
Eur Radiol; 2014 Dec; 24(12):3134-41. PubMed ID: 25100335
[TBL] [Abstract][Full Text] [Related]
10. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of patients with concomitant intraductal papillary mucinous neoplasm of the pancreas and pancreatic endocrine neoplasm.
Goh BK; Ooi LL; Kumarasinghe MP; Tan YM; Cheow PC; Chow PK; Chung YF; Wong WK
Pancreatology; 2006; 6(6):520-6. PubMed ID: 17124434
[TBL] [Abstract][Full Text] [Related]
12. Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm.
Malleo G; Marchegiani G; Borin A; Capelli P; Accordini F; Butturini G; Pederzoli P; Bassi C; Salvia R
Ann Surg; 2015 May; 261(5):984-90. PubMed ID: 25493361
[TBL] [Abstract][Full Text] [Related]
13. High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms.
Choi MG; Kim SW; Han SS; Jang JY; Park YH
Arch Surg; 2006 Jan; 141(1):51-6; discussion 56. PubMed ID: 16415411
[TBL] [Abstract][Full Text] [Related]
14. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
15. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
16. Intraductal papillary mucinous neoplasm of the pancreas, one manifestation of a more systemic disease?
Roch AM; Rosati CM; Cioffi JL; Ceppa EP; DeWitt JM; Al-Haddad MA; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
Am J Surg; 2016 Mar; 211(3):512-8. PubMed ID: 26830712
[TBL] [Abstract][Full Text] [Related]
17. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis.
Manfredi R; Graziani R; Motton M; Mantovani W; Baltieri S; Tognolini A; Crippa S; Capelli P; Salvia R; Pozzi Mucelli R
Radiology; 2009 Oct; 253(1):106-15. PubMed ID: 19703865
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN.
Yamaguchi K; Kanemitsu S; Hatori T; Maguchi H; Shimizu Y; Tada M; Nakagohri T; Hanada K; Osanai M; Noda Y; Nakaizumi A; Furukawa T; Ban S; Nobukawa B; Kato Y; Tanaka M
Pancreas; 2011 May; 40(4):571-80. PubMed ID: 21499212
[TBL] [Abstract][Full Text] [Related]
19. Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm.
Miyasaka Y; Ohtsuka T; Tamura K; Mori Y; Shindo K; Yamada D; Takahata S; Ishigami K; Ito T; Tokunaga S; Oda Y; Mizumoto K; Nakamura M; Tanaka M
Ann Surg; 2016 Jun; 263(6):1180-7. PubMed ID: 26334637
[TBL] [Abstract][Full Text] [Related]
20. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.
Sahora K; Crippa S; Zamboni G; Ferrone C; Warshaw AL; Lillemoe K; Mino-Kenudson M; Falconi M; Fernandez-del Castillo C
Eur J Surg Oncol; 2016 Feb; 42(2):197-204. PubMed ID: 26687069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
